Li N - Search Results

1

Identifying a Novel Eight-NK Cell-related Gene Signature for Ovarian Cancer Prognosis Prediction.

Li N, Yu K, Huang D, Zhou H, Zeng D. Li N, et al. Curr Med Chem. 2024;31(12):1578-1594. doi: 10.2174/0929867331666230831101847. Curr Med Chem. 2024. PMID: 37650393

2

Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.

Li N, Yu K, Lin Z, Zeng D. Li N, et al. Comb Chem High Throughput Screen. 2021;24(2):233-245. doi: 10.2174/1386207323999200729113641. Comb Chem High Throughput Screen. 2021. PMID: 32729416

3

Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations.

Li N, Yu K, Lin Z, Zeng D. Li N, et al. Exp Biol Med (Maywood). 2022 Feb;247(3):207-220. doi: 10.1177/15353702211053580. Epub 2021 Oct 21. Exp Biol Med (Maywood). 2022. PMID: 34674573 Free PMC article.

4

Identifying immune subtypes of uterine corpus endometrial carcinoma and a four-paired-lncRNA signature with immune-related lncRNAs.

Li N, Yu K, Lin Z, Zeng D. Li N, et al. Exp Biol Med (Maywood). 2022 Feb;247(3):221-236. doi: 10.1177/15353702211053588. Epub 2021 Oct 27. Exp Biol Med (Maywood). 2022. PMID: 34704492 Free PMC article.

5

Development of a Novel Immune Subtyping System Expanded with Immune Landscape and an 11-Gene Signature for Predicting Prostate Cancer Survival.

Li N, Yu K, Lin Z, Zeng D. Li N, et al. J Oncol. 2022 Feb 16;2022:1183173. doi: 10.1155/2022/1183173. eCollection 2022. J Oncol. 2022. PMID: 35222640 Free PMC article.

6

Molecular Characterization of Cuproptosis-related lncRNAs: Defining Molecular Subtypes and a Prognostic Signature of Ovarian Cancer.

Li N, Yu K, Huang D, Li S, Zeng D, Li J, Fan L. Li N, et al. Among authors: li s, li j. Biol Trace Elem Res. 2024 Apr;202(4):1428-1445. doi: 10.1007/s12011-023-03780-3. Epub 2023 Aug 2. Biol Trace Elem Res. 2024. PMID: 37528285

7

Elucidating the Role of Autophagy-related Genes in Polycystic Ovary Syndrome: Implications for Diagnostic Models and Immune Response Regulation.

Li N, Yu K, Huang D, Guo H, Zhu X, Lin Z. Li N, et al. Curr Med Chem. 2024 Oct 17. doi: 10.2174/0109298673337033241010072529. Online ahead of print. Curr Med Chem. 2024. PMID: 39421991

8

Ferritin light chain as a potential biomarker for the prognosis of liver hepatocellular carcinoma.

Li A, Li Y, Li X, Tang C, Yang Y, Li N, Jin Y. Li A, et al. Among authors: li y, li x, li n. Heliyon. 2024 Aug 9;10(16):e36040. doi: 10.1016/j.heliyon.2024.e36040. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39224384 Free PMC article.

9

ENU-based dominant genetic screen identifies contractile and neuronal gene mutations in congenital heart disease.

Luo X, Liu L, Rong H, Liu X, Yang L, Li N, Shi H. Luo X, et al. Among authors: li n. Genome Med. 2024 Aug 12;16(1):97. doi: 10.1186/s13073-024-01372-x. Genome Med. 2024. PMID: 39135118 Free PMC article.

10

Identification of candidate miRNA biomarkers correlated with the prognosis of cell carcinoma and endocervical adenocarcinoma via integrated bioinformatics analysis.

Zhi S, Jiang B, Yu W, Li Y, Wang H, Zhou T, Li N. Zhi S, et al. Among authors: li y, li n. Am J Transl Res. 2022 Nov 15;14(11):8146-8155. eCollection 2022. Am J Transl Res. 2022. PMID: 36505295 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,801 results

Search Page

Filters